UNSPSC 51383801: Adapalene

This classification denotes a retinoic acid agent with the molecular formula C28H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1L4806J2QF, chemically known as 2-naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo(3.3.1.1(sup 3,7))dec-1-ylphenyl)- but generally known as adapalene, which bears US NIH Compound Identifier 60164. European Medicines Agency schedules Adapalene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05261MIG.

UNSPSC 51383801 Adapalene is a Commodity code, but the recent state and local opportunities tagged under it involve naloxone, safe drug deactivation systems, direct-to-manufacturer pharmaceutical programs, and generic multi-source pharmaceuticals and OTC products — none of which align with adapalene (a topical retinoid acne medication). The code shows little relevant recent activity; the opportunities present appear to reflect pharmaceutical procurement at scale rather than the specialty dermatological product the code nominates.

The three recent opportunities do demonstrate broader state and local pharmaceutical and health-product procurement activity. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries. The Texas Health and Human Services Commission posted an RFI (HHS0017013, due April 3, 2026) to gather vendor capability information on direct-to-manufacturer prescription programs for state health plans. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802, due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products distributed to state and local government facilities across participating jurisdictions including Oregon, with contract effectiveness July 1, 2026 and a 3 percent administrative fee structure. Across these opportunities, issuing bodies include county health departments, state HHS agencies, and cooperative purchasing alliances serving multiple states. Geographic activity centers on Florida, Texas, and Minnesota. The mismatch between the adapalene code and the pharmaceutical procurement activity represented in these recent opportunities suggests that vendors should verify code assignment against actual scope before pursuing opportunities tagged under this Commodity code.